BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 29630097)

  • 1. Regulation of FGF2-induced proliferation by inhibitory GPCR in normal pituitary cells.
    Sosa LDV; Picech F; Perez P; Gutierrez S; Leal RB; De Paul A; Torres A; Petiti JP
    Front Endocrinol (Lausanne); 2023; 14():1183151. PubMed ID: 37576961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.
    Shojaee S; Caeser R; Buchner M; Park E; Swaminathan S; Hurtz C; Geng H; Chan LN; Klemm L; Hofmann WK; Qiu YH; Zhang N; Coombes KR; Paietta E; Molkentin J; Koeffler HP; Willman CL; Hunger SP; Melnick A; Kornblau SM; Müschen M
    Cancer Cell; 2015 Jul; 28(1):114-28. PubMed ID: 26073130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Fibroblast Growth Factors Caused by Heart and Neural Crest Derivatives Expressed 2 Suppression in Endometriotic Cells: A Possible Therapeutic Target in Endometriosis.
    Kato N; Iwase A; Ishida C; Nagai T; Mori M; Bayasula ; Nakamura T; Osuka S; Ganiyeva U; Qin Y; Miki R; Kikkawa F
    Reprod Sci; 2019 Jul; 26(7):979-987. PubMed ID: 30270745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeic Acid Phenethyl Ester Reduces the Adverse Effects of Nicotine on the Endometrium.
    Namdari A; Miladpour B
    Iran J Med Sci; 2023 Sep; 48(5):493-500. PubMed ID: 37786469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR30-mediated non-classic estrogen pathway in mast cells participates in endometriosis pain
    Xu X; Wang J; Guo X; Chen Y; Ding S; Zou G; Zhu L; Li T; Zhang X
    Front Immunol; 2023; 14():1106771. PubMed ID: 36845134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer.
    Francavilla C; O'Brien CS
    Open Biol; 2022 Feb; 12(2):210373. PubMed ID: 35193394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sprouty proteins: antagonists of endothelial cell signaling and more.
    Cabrita MA; Christofori G
    Thromb Haemost; 2003 Oct; 90(4):586-90. PubMed ID: 14515177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of FGF2 on the activity of SPRYs/DUSP6/ERK signaling pathway in endometrial glandular epithelial cells of endometriosis.
    Yu XY; Wang XT; Chu YL; Qu HM; Liu J; Zhang YH; Li MJ
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1554-1568. PubMed ID: 29630097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of fibroblast growth factor 2 contributes to endometriosis through SPRYs/DUSP6/ERK signaling pathway.
    Yu X; Wang Y; Tan X; Li M
    Acta Histochem; 2021 Jul; 123(5):151749. PubMed ID: 34224989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of expressions of Dusp6, Sprouty4, and Sef, negative regulators of FGF2/ERK1/2 signaling, in the endometrium of women with adenomyosis.
    Guo Q; Zhang H; Zhao X; Fu Y; Zhang J; Li M
    Int J Gynecol Pathol; 2014 May; 33(3):288-97. PubMed ID: 24681741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-specificity phosphatase 6 (Dusp6), a negative regulator of FGF2/ERK1/2 signaling, enhances 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell.
    Zhang H; Guo Q; Wang C; Yan L; Fu Y; Fan M; Zhao X; Li M
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):60-9. PubMed ID: 23419500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM65 Promotes Invasion of Endometrial Stromal Cells by Activating ERK1/2/C-myc Signaling via Ubiquitination of DUSP6.
    Wu YT; Ma SY; Sun WQ; Shen WW; Zhu HT; Zhang Q; Chen HF
    J Clin Endocrinol Metab; 2021 Jan; 106(2):526-538. PubMed ID: 33146694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels.
    Lai WT; Krishnappa V; Phinney DG
    Stem Cells; 2011 Jul; 29(7):1102-11. PubMed ID: 21608080
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.